Replies to post #4146 on RespireRx Pharmaceuticals Inc (fka RSPI)

[wahjjhugo]

<<Could the in-licensing thing be part of a deal for the high impacts??? >>

I like that thought but the slide (#30 from the presentation) doesn't read that way.
Also, will Cortex hold off on a deal for CX717 until after the AD-Pet Scan study results are in? That's Q3, 2007. There are so many scenarios. I agree there must be much we don't know if Cortex is set on an in-licensing in Q2 '07